Inventor
FUH GERMAINE
US38 patents
⚠️ This page may combine multiple inventors who share the name “FUH GERMAINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
27 patentsUS7985840B2Jul 26, 2011
Synthetic antibody phage libraries
GENENTECH INC112 citations98
US7691977B2Apr 6, 2010
Anti-VEGF antibodies
GENENTECH INC83 citations98
US7758859B2Jul 20, 2010
Anti-VEGF antibodies
GENENTECH INC76 citations97
US7811785B2Oct 12, 2010
Anti-VEGF antibodies
GENENTECH INC32 citations96
US6429186B1Aug 6, 2002
Ligand antagonists for treatment of breast cancer
GENENTECH INC77 citations96
US10072075B2Sep 11, 2018
Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesis
GENENTECH INC17 citations92
US7910098B2Mar 22, 2011
Anti-VEGF antibodies
GENENTECH INC27 citations92
US11007267B2May 18, 2021
Anti-CD3 antibodies and methods of use
GENENTECH INC8 citations83
US9353177B2May 31, 2016
Anti-VEGF antibodies
GENENTECH INC8 citations83
US9018357B2Apr 28, 2015
Anti-VEGF antibodies
GENENTECH INC4 citations83
US8975381B2Mar 10, 2015
Anti-VEGF antibodies
GENENTECH INC5 citations83
US11111291B2Sep 7, 2021
Conjugates comprising a vascular endothelial growth factor (VEGF) antibody and a hyaluronic acid polymer
GENENTECH INC6 citations82
US10899828B2Jan 26, 2021
Optimized variants of anti-vegf antibodies and methods of use thereof in treatment
GENENTECH INC5 citations82
US9327035B2May 3, 2016
Anti-HER antibodies
GENENTECH INC8 citations82
US11891437B2Feb 6, 2024
Methods of treating ocular disorders by administering a VEGF-binding antibody covalently linked to a hyaluronic acid polymer
GENENTECH INC3 citations73
US10683348B2Jun 16, 2020
Dual specific antibodies
GENENTECH INC3 citations72
US11512143B2Nov 29, 2022
Anti-HtrA1 antibodies and methods of use thereof
GENENTECH INC1 citations71
US11008401B2May 18, 2021
Multispecific antibodies
GENENTECH INC4 citations71
US10906968B2Feb 2, 2021
Polynucleotides encoding optimized variants of anti-VEGF antibodies
GENENTECH INC2 citations71
US10421822B2Sep 24, 2019
Anti-HtrA1 antibodies and methods of use thereof
GENENTECH INC4 citations71
US10421821B2Sep 24, 2019
Anti-HtrA1 antibodies and methods of use thereof
GENENTECH INC2 citations71
US9777059B2Oct 3, 2017
Anti-VEGF antibodies
GENENTECH INC1 citations62
US12121586B2Oct 22, 2024
Optimized variants of anti-VEGF antibodies
GENENTECH INC0 citations61
US12006360B2Jun 11, 2024
Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)
GENENTECH INC0 citations61
US11851501B2Dec 26, 2023
Multispecific antibodies
GENENTECH INC0 citations61
US9522960B2Dec 20, 2016
Multispecific antibodies
GENENTECH INC0 citations50
US9102720B2Aug 11, 2015
Anti-VEGF-C antibodies and methods using same
GENENTECH INC1 citations48
FUH GERMAINE
7 patentsUS8512699B2Aug 20, 2013
Anti-VEGF antibodies
FUH GERMAINE21 citations92
US8492527B2Jul 23, 2013
Anti-VEGF antibodies
FUH GERMAINE21 citations92
US8101177B2Jan 24, 2012
Anti-VEGF antibodies
FUH GERMAINE22 citations92
US8092797B2Jan 10, 2012
Anti-VEGF antibodies
FUH GERMAINE19 citations92
US10118970B2Nov 6, 2018
Multispecific antibodies
FUH GERMAINE5 citations82
US8597652B2Dec 3, 2013
Multispecific anti-HER antibodies
FUH GERMAINE10 citations82
US8921537B2Dec 30, 2014
Anti-VEGF antibodies
FUH GERMAINE4 citations72